Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA

被引：63
|
作者：
Ballatore, C
McGuigan, C
De Clercq, E
Balzarini, J
机构：
[1] Univ Wales Coll Cardiff, Welsh Sch Pharm, Cardiff CF10 3XF, S Glam, Wales
[2] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 08期
关键词：
D O I：
10.1016/S0960-894X(01)00128-7
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Some novel amidate prodrugs of PMEA and PMPA have been synthesised and tested in vitro for their biological activity. Compound 5 in particular showed greatly enhanced antiviral potency compared with the parent nucleotide analogue. In vitro enzymatic studies and structure-activity relationships indicate that the degradation mechanism of such prodrugs may be the same as that described for the phosphoramidate triesters of nucleotide analogues. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：1053 / 1056
页数：4
相关论文
共 50 条
  • [21] NEW PRODRUGS OF 9-(2-PHOSPHONOMETHOXYETHYL) ADENINE [PMEA] - SYNTHESIS AND STABILITY STUDIES
    BENZARIA, S
    GOSSELIN, G
    PELICANO, H
    MAURY, G
    AUBERTIN, AM
    OBERT, G
    KIRN, A
    IMBACH, JL
    NUCLEOSIDES & NUCLEOTIDES, 1995, 14 (3-5): : 563 - 565
  • [22] PMEA and PMPA: Acyclic nucleoside phosphonates with potent anti-HIV activity.
    Cihlar, T
    Bischofberger, N
    TRENDS IN DRUG RESEARCH II, 1998, 29 : 105 - 116
  • [23] Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds: in vitro analyses
    Mulato, AS
    Cherrington, JM
    ANTIVIRAL RESEARCH, 1997, 36 (02) : 91 - 97
  • [24] SYNTHESIS, ORAL BIOAVAILABILITY DETERMINATION, AND IN-VITRO EVALUATION OF PRODRUGS OF THE ANTIVIRAL AGENT 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE (PMEA)
    STARRETT, JE
    TORTOLANI, DR
    RUSSELL, J
    HITCHCOCK, MJM
    WHITEROCK, V
    MARTIN, JC
    MANSURI, MM
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (12) : 1857 - 1864
  • [25] Novel amides and esters prodrugs of olmesartan: Synthesis, bioconversion, and pharmacokinetic evaluation
    Park, Jin-Hun
    Chang, Jeong-Soo
    El-Gamal, Mohammed I.
    Choi, Won-Kyoung
    Lee, Woong San
    Chung, Hye Jin
    Kim, Hyun-Il
    Cho, Young-Jin
    Lee, Bong Sang
    Jeon, Hong-Ryeol
    Lee, Yong Sup
    Choi, Young Wook
    Lee, Jaehwi
    Oh, Chang-Hyun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) : 5895 - 5899
  • [26] Synthesis and evaluation of novel biotin conjugated lipid prodrugs of cyclic cidofovir
    Bagui, Mahuya
    Gokulgandhi, Mitan R.
    Mitra, Ashim K.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [27] Design, synthesis and evaluation of novel cyclophosphamide prodrugs for reductive activation.
    Jiang, YY
    Yu, CZ
    Han, JY
    Browne, P
    Knox, RJ
    Hu, LQ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U46 - U46
  • [28] Design, synthesis and initial in vitro evaluation of novel prodrugs for the treatment of cystinosis
    Anderson, RJ
    Cairns, D
    Cardwell, WA
    Case, M
    Groundwater, PW
    Hall, AG
    Hogarth, L
    Jones, AL
    Meth-Cohn, O
    Suryadevara, P
    Tindall, A
    Thoene, JG
    LETTERS IN DRUG DESIGN & DISCOVERY, 2006, 3 (05) : 336 - 345
  • [29] Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaques
    Silvera, P
    Racz, P
    Racz, K
    Bischofberger, N
    Crabbs, C
    Yalley-Ogunro, J
    Greenhouse, J
    Jiang, JB
    Lewis, MG
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (08) : 791 - 800
  • [30] LC/MS determination of the intracellular concentration of two novel aryl phosphoramidate prodrugs of PMPA and their metabolites in dog PBMC
    Lynch, T
    Eisenberg, G
    Kernan, M
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7): : 1415 - 1419
12345